稳心颗粒应用于治疗房颤的研究进展

The development of research on the application of Wenxin granule on the treatment of atrial fibrillation

步长稳心颗粒作为一个抗心律失常的中药组方,是中国第一个被证明能调节多离子通道的抗心律失常专利中成药,在临床上广泛应用于各种类型的房颤患者的治疗。本文通过检索近年公开发表在国家级刊物上有关稳心颗粒治疗房颤的论文,汇总并评估其疗效及安全性。

Wenxin granule is the first Traditional Chinese Medicine proved to be effective in regulating the multiple iron channel in China. It is widely used in the clinical treatment of atrial fibrillation of all types. This paper evaluates its curative efficacy and security on treating atrial fibrillation by retrieved the relevant thesis published on national publications in recent years.